Status:
UNKNOWN
Neurostimulation in Intermittent Claudication
Lead Sponsor:
The Leeds Teaching Hospitals NHS Trust
Conditions:
Claudication
Eligibility:
All Genders
50-90 years
Phase:
NA
Brief Summary
Intermittent claudication is a condition where a patient suffers with cramp-like pain experienced in the muscles of the legs (often the calf muscles) brought on by walking and relieved by stopping wal...
Detailed Description
Lower limb peripheral arterial disease (PAD) is common, affecting over 200 million people worldwide and present in 12 to 14% of the global population (20% over the age of 75 years)1. The most common s...
Eligibility Criteria
Inclusion
- • Rutherford b/c intermittent claudication with stable symptoms for 6 months with a decision not to undergo any revascularization.
Exclusion
- • Critical limb ischaemia
- Previous external ear surgery
- Patients with either a cochlear implant or a permanent pacemaker / cardiac defibrillator device
- Significant cardiorespiratory or musculoskeletal disease (as determined by the medical team) that would contraindicate a 6-minute walk test
Key Trial Info
Start Date :
June 26 2023
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
December 31 2023
Estimated Enrollment :
16 Patients enrolled
Trial Details
Trial ID
NCT06176898
Start Date
June 26 2023
End Date
December 31 2023
Last Update
December 20 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Leeds Teaching Hospitals NHS Trust
Leeds, United Kingdom, LS9 7TF